%0 Journal Article
%A Martín Escura, Cristina
%A Medina Peris, Alicia
%A Spear, Luke A.
%A de la Torre Martínez, Roberto
%A Olivos Ore, Luis Alcides
%A Barahona Gomáriz, María Victoria
%A González Rodríguez de Castro, Sara
%A Fernández Ballester, Gregorio
%A Fernández Carvajal, Asia
%A Rodríguez Artalejo, Antonio
%A Ferrer Montiel, Antonio
%A González Muñiz, Rosario
%T β–Lactam TRPM8 Antagonist RGM8-51 Displays Antinociceptive Activity in Different Animal Models
%D 2022
%@ 1422-0067
%U https://hdl.handle.net/20.500.14352/72502
%X Transient receptor potential melastatin subtype 8 (TRPM8) is a cation channel extensively expressed in sensory neurons and implicated in different painful states. However, the effectiveness of TRPM8 modulators for pain relief is still a matter of discussion, since structurally diverse modulators lead to different results, depending on the animal pain model. In this work, we described the antinociceptive activity of a β–lactam derivative, RGM8-51, showing good TRPM8 antagonist activity, and selectivity against related thermoTRP channels and other pain-mediating receptors. In primary cultures of rat dorsal root ganglion (DRG) neurons, RGM8-51 potently reduced menthol-evoked neuronal firing without affecting the major ion conductances responsible for action potential generation. This compound has in vivo antinociceptive activity in response to cold, in a mouse model of oxaliplatin-induced peripheral neuropathy. In addition, it reduces cold, mechanical and heat hypersensitivity in a rat model of neuropathic pain arising after chronic constriction of the sciatic nerve. Furthermore, RGM8-51 exhibits mechanical hypersensitivity-relieving activity, in a mouse model of NTG-induced hyperesthesia. Taken together, these preclinical results substantiate that this TRPM8 antagonist is a promising pharmacological tool to study TRPM8-related diseases.
%~